Schedule of Summarizes Information About Stock Options (Details) (Parenthetical) - shares	6 Months Ended	12 Months Ended
Jun. 30, 2024	Dec. 31, 2023
2018 Equity Plan [Member] \| Lucid Diagnostics Inc [Member]
Number of stock options granted. shares	523,300	523,300
Parent Company [Member] \| 2014 Equity Plan [Member]
Number of stock options granted. shares	60,054	60,054

Net number of share options (or share units) granted during the period.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration